Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 2
2005 2
2007 4
2008 4
2009 4
2010 5
2011 2
2012 5
2013 14
2014 10
2015 7
2016 15
2017 9
2018 25
2019 35
2020 19
2021 35
2022 34
2023 34
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L, Zhang Y, Shen S, Wang X, Dong L, Li Q, Ren W, Li Y, Bai J, Gong Q, Kuang H, Qi L, Lu Q, Cheng W, Liu Y, Yan S, Wu D, Fang H, Hou F, Wang Y, Yang Z, Lian X, Du J, Sun N, Ji L, Li G; China Diabetes Prevention Program Study Group. Zhang L, et al. Lancet Diabetes Endocrinol. 2023 Aug;11(8):567-577. doi: 10.1016/S2213-8587(23)00132-8. Epub 2023 Jul 3. Lancet Diabetes Endocrinol. 2023. PMID: 37414069 Clinical Trial.
Probiotics and irritable bowel syndrome.
Dai C, Zheng CQ, Jiang M, Ma XY, Jiang LJ. Dai C, et al. World J Gastroenterol. 2013 Sep 28;19(36):5973-80. doi: 10.3748/wjg.v19.i36.5973. World J Gastroenterol. 2013. PMID: 24106397 Free PMC article. Review.
The prevalence of osteoporosis in China, a community based cohort study of osteoporosis.
Wang J, Shu B, Tang DZ, Li CG, Xie XW, Jiang LJ, Jiang XB, Chen BL, Lin XC, Wei X, Leng XY, Liao ZY, Li BL, Zhang Y, Cui XJ, Zhang Q, Lu S, Shi Q, Wang YJ. Wang J, et al. Front Public Health. 2023 Feb 16;11:1084005. doi: 10.3389/fpubh.2023.1084005. eCollection 2023. Front Public Health. 2023. PMID: 36875399 Free PMC article.
Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.
Vos MB, Dimick-Santos L, Mehta R, Omokaro SO, Taminiau J, Schabel E, Kleiner DE, Szitanyi P, Socha P, Schwimmer JB, Noviello S, Silberg DG, Torstenson R, Miller V, Lavine JE; Liver Forum Pediatric Working Group. Vos MB, et al. Gastroenterology. 2019 Dec;157(6):1448-1456.e1. doi: 10.1053/j.gastro.2019.08.048. Epub 2019 Sep 12. Gastroenterology. 2019. PMID: 31520612 Free PMC article. No abstract available.
Primary resistance to integrase inhibitors in Shenzhen.
Zhu Y, Huang Y, Zheng C, Tang J, Zeng G, Xie W, Wang H, Zhang L, Liu S, Zhang Y, Tan W, Tan J, Jiang L, He Y, Xu L, Yang Z, Zhao J. Zhu Y, et al. Among authors: jiang l. J Antimicrob Chemother. 2023 Feb 1;78(2):546-549. doi: 10.1093/jac/dkac442. J Antimicrob Chemother. 2023. PMID: 36585770
248 results